Consonance Capital Management LP 13D/13G Filings for Protagonist Therapeutics, Inc. (PTGX)

Consonance Capital Management LP 13D and 13G filings for Protagonist Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
1:57 pm
Sale
2021-12-3113GPROTAGONIST THERAPEUTICS INC C
PTGX
Consonance Capital Management LP0
0.000%
-2,729,709decrease
(Position Closed)
Filing